As a trusted partner for pharmaceutical companies, Akesa Access plays a crucial role in supporting patient access programs. We recognise the significance of these programs in providing patients with life-saving medication for serious and rare diseases.
Our team of dedicated pharmacists with extensive expertise, supported by a centralised community pharmacy, provides Direct to Patient services that cater to the unique needs of each medicine. With a focus on delivering superior service, we work closely with our clients to deliver patient access programs that change and improve lives.
Managed Access Programs
Managed Access Programs play a pivotal role in bridging the gap between clinical trials and a product’s widespread market availability. They’re designed to provide patients with novel treatments that are not yet publicly accessible. Akesa helps sponsors with program development and integration with existing processes to ensure that these treatments are delivered efficiently and safely.
Our Managed Access Programs are provided via a central PBS licensed pharmacy, boasting national coverage, ensuring timely and compliant distribution of treatments across regions.
We work with our sponsors to develop all stages of a Managed Access Program, including:
- Post Clinical Trial
- Pre-registration & Pre-reimbursement
- Product Familiarisation Programs
- Expanded Access Programs
At Akesa, we believe that innovation is the key to driving progress and transforming lives. We are dedicated to supporting the discovery and development of ground-breaking pharmaceuticals, and our Managed Access Programs reflect this commitment. We strive to find solutions where others may not, and our team of experts work tirelessly to ensure your program succeeds.
Patient-centric services for sponsors
Akesa Access embodies the pioneering spirit of Akesa by delivering bespoke Clinical Trial Services that are designed to provide patients with access to cutting-edge pharmaceuticals.
Our distribution channels are optimised for both Direct to Site (DTS) through partnerships with World Courier, and Direct to Patient (DTP) via a centralised pharmacy.
We understand that providing Direct to Patient services can be a challenging task, but our focus on quality and reliability ensures that every aspect of our service meets the highest standards.
Next-level hospital pharmacy site solutions
CT Connect is our on-demand hospital pharmacy site solution that minimises the red tape involved in getting your medicine into the hands of your patients. By working with Akesa, sponsors can streamline the supply chain and feel confident in knowing that we handle all aspects of communication between the wholesaler and the clinical trial site, hospital or pharmacy.
We work closely with our clients to develop customised programs that are tailored to their specific needs, and our team is always available to answer questions and provide support throughout the process.
To learn more about Akesa Access and our Managed Access Programs, please contact us. Our team is always happy to answer any questions you may have and provide additional information about our services. Thank you for considering Akesa Access for your Managed Access needs.